Cargill and BAR Technologies’ Ground-Breaking Wind Technology Sets Sail, Chartering a New Lower-Carbon Path for the Maritime Industry
21.8.2023 08:00:00 EEST | Business Wire | Press release
Cargill and BAR Technologies’ ground-breaking innovation, BAR Tech WindWings by Yara Marine sets sail on open waters, testing new technology that will bring cutting edge wind propulsion to commercial shipping for the first time.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230820864494/en/
Cargill and BAR Technologies’ ground-breaking wind technology sets sail, chartering a new lower-carbon path for the maritime industry. (Photo: Business Wire)
Mitsubishi Corporation’s Pyxis Ocean, chartered by Cargill, is the first vessel to be retrofitted with two WindWings, which are large wing sails measuring up to 37,5 meters in height that can be fitted to the deck of cargo ships to harness the power of wind. Produced by industrialization partner Yara Marine Technologies, they are expected to generate average fuel savings of up to 30 percent on new build vessels, which could be even higher if used in combination with alternative fuels. The installation of the wings took place at the COSCO shipyard in China and the Pyxis Ocean is now on the water, conducting her maiden voyage.
“The maritime industry is on a journey to decarbonize—it's not an easy one, but it is an exciting one,” said Jan Dieleman, President of Cargill’s Ocean Transportation business. “At Cargill we have a responsibility to pioneer decarbonizing solutions across all our supply chains to meet our customer’s needs and the needs of the planet. A technology like WindWings doesn’t come without risk, and as an industry leader – in partnership with visionary shipowner Mitsubishi Corporation - we are not afraid to invest, take those risks and be transparent with our learnings to help our partners in maritime transition to a more sustainable future.”
The installation demonstrates a step-change in attitudes towards technologies that can enable an energy transition for existing vessels. The WindWings project, which is co-funded by the European Union as part of the CHEK Horizon 2020 initiative, can help the industry meet those targets by offering a retrofit solution that is capable of decarbonizing existing vessels, which is particularly relevant given that 55 percent of the world’s bulker fleets are up to nine years in age.
The performance of the WindWings will be closely monitored over the coming months to further improve their design, operation, and performance, with the aim that the Pyxis Ocean will be used to inform the scale-up and adoption across not only Cargill’s fleet but the industry. BAR Technologies and Yara Marine Technologies are already planning to build hundreds of wings over the next four years and BAR Technologies is also researching newbuilds with improved hydrodynamic hull forms.
“If international shipping is to achieve its ambition of reducing CO2 emissions, then innovation must come to the fore. Wind is a near marginal cost-free fuel and the opportunity for reducing emissions, alongside significant efficiency gains in vessel operating costs, is substantial. Today is the culmination of years of pioneering research, where we’ve invested in our unique wind sail technology and sought out a skilled industrialization partner in Yara Marine Technologies, in order to provide vessel owners and operators with an opportunity to realize these efficiencies,” said John Cooper, Chief Executive Officer, BAR Technologies.
More about the WindWing Project
- The WindWing project is part of a project that has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 955286.
- By harnessing the power of wind, WindWings can help vessel owners meet new CII rules. As wind power is not only zero emissions but is also non-depleting and hugely predictable, it offers significant efficiency gains in vessel operating costs.
- On an average global route, WindWings can save 1.5 tonnes of fuel per WindWing per day - with the possibility of saving more on trans ocean routes. This can translate into vessel owners saving heavy fuel oil (HFO) at c$800 per tonne, which will become even more important when saving against future fuels which will undoubtedly cost a lot more.
About Cargill
Cargill helps the world’s food system work for you. We connect farmers with markets, customers with ingredients and families with daily essentials—from the foods they eat to the floors they walk on. Our 160,000 team members around the world innovate with purpose, empowering our partners and communities as we work to nourish the world in a safe, responsible, sustainability way.
From the feed that reduces methane emissions to waste-based renewable fuels, the possibilities are boundless. But our values remain the same. We put people first. We reach higher. We do the right thing. It’s how we’ve met the needs of the people we call neighbors and the planet we call home for 158 years—and how we’ll do so for generations to come. For more information, visit Cargill.com and our News Center.
About BAR Technologies
With an impressive heritage, having originally spun out from the former British, America’s Cup Team, BAR Tech provides a wide range of design and engineering consultancy services with a focus on 4 key sectors; Workboats and Commercial Vessels, Shipping, Special Projects and Leisure Marine and Yachts.
BAR Technologies offer a cohesive team of world lead naval architects and optimisation specialists; fluid dynamists; mechanical, structural and composite engineers; control strategy and system specialists; they offer data and simulation engineers with access to the latest commercial knowledge, using bespoke in-house design tools.
For more details please visit: https://www.bartechnologies.uk/
About Yara Marine Technologies
Yara Marine (YMT) provides technologies to enable a greener maritime industry. Since 2010, YMT has been at the forefront of maritime emissions reduction, working closely with ship-owners, yards, and naval architects as partners in our effort to drive the change towards sustainable shipping. Today, Yara Marine offers a portfolio of green technologies, such as SOx scrubbers, fuel optimization systems – FuelOpt and Fleet Analytics, turnkey shore power solutions, and the cutting-edge, advanced wind-assisted propulsion system WindWings. Yara Marine is headquartered in Oslo, Norway, with offices in Sweden, Poland, and China.
To learn more, please visit www.yaramarine.com or follow YMT on LinkedIn.
About Mitsubishi Corporation
Head Office: 3-1, Marunouchi 2-Chome, Chiyoda-ku, Tokyo, 100-8086, Japan
Representative: Katsuya Nakanishi, Representative Director, President and Chief Executive Officer
Date Established: July 1, 1954 (Date Registered April 1, 1950)
Main Operations: MC engages in a wide range of businesses spanning multiple industries and overseen by its Industry DX Group, Next-Generation Energy Business Group and 10 Business Groups: Natural Gas, Industrial Materials, Chemicals Solution, Mineral Resources, Industrial Infrastructure, Automotive & Mobility, Food Industry, Consumer Industry, Power Solution, and Urban Development.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230820864494/en/
Contact information
Nicole Marlor, media@cargill.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release
International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release
Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
